Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06).

Levy Y, Moog C, Wiedemann A, Launay O, Candotti F, Hardel L, Durand M, Rieux V, Diallo A, Lacabaratz C, Cardinaud S, Zurawski S, Zurawski G, Tomaras GD, Ding S, Centlivre M, Thiebaut R, Pantaleo G, Lelièvre JD, Richert L, ANRS VRI06 Study Group

Open source

DOI: 10.1016/j.eclinm.2024.102845
Published: 2024 Nov
Container: EClinicalMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2024.102845,
  title = {Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06).},
  author = {Levy Y and Moog C and Wiedemann A and Launay O and Candotti F and Hardel L and Durand M and Rieux V and Diallo A and Lacabaratz C and Cardinaud S and Zurawski S and Zurawski G and Tomaras GD and Ding S and Centlivre M and Thiebaut R and Pantaleo G and Lelièvre JD and Richert L and ANRS VRI06 Study Group},
  year = {2024},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2024.102845},
  url = {https://doi.org/10.1016/j.eclinm.2024.102845}
}

RIS

TY  - JOUR
TI  - Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06).
AU  - Levy Y
AU  - Moog C
AU  - Wiedemann A
AU  - Launay O
AU  - Candotti F
AU  - Hardel L
AU  - Durand M
AU  - Rieux V
AU  - Diallo A
AU  - Lacabaratz C
AU  - Cardinaud S
AU  - Zurawski S
AU  - Zurawski G
AU  - Tomaras GD
AU  - Ding S
AU  - Centlivre M
AU  - Thiebaut R
AU  - Pantaleo G
AU  - Lelièvre JD
AU  - Richert L
AU  - ANRS VRI06 Study Group
PY  - 2024
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2024.102845
UR  - https://doi.org/10.1016/j.eclinm.2024.102845
ER  -

APA

Y, L., C, M., A, W., O, L., F, C., L, H., M, D., V, R., A, D., C, L., S, C., S, Z., G, Z., GD, T., S, D., M, C., R, T., G, P., JD, L., L, R., & Group, A. V. S. (2024). Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06).. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2024.102845

Source records

pubmed · retrieved 2026-09-26T03:32:07.738Z